Valsartan Drug Recall & Injury
This Case involves:
Anyone who was prescribed Valsartan to treat hypertension, heart attacks and heart failure, and who developed digestive tract cancer or severe liver damage as a result of taking doses of the drug that were produced in overseas labs, and that were tainted or contaminated with the carcinogenic chemicals NDMA. Claimants should obtain documented proof from their health care providers or hospitals that their cancer or liver damage was directly attributable to contaminated Valsartan.
Lawsuits have been filed nationwide against the pharmaceutical companies who were allegedly involved in manufacturing the contaminated drugs. The suits have been consolidated in federal court in New Jersey. Many suits also allege liver cancer, colorectal cancer, kidney damage and cancer, and gastric cancer. Plaintiffs claim that defendants were aware of the tainted lots as early as 2012 but did not warn doctors and patients. Because the various lawsuits in the mass tort case are still relatively new and more are gradually being filed, the possible settlement dollar value cannot yet be determined.
Valsartan is an angiotensin II receptor blocker prescribed by physicians for the treatment of hypertension, heart attacks and heart failure. It is also used to treat some effects of diabetes. A naturally occurring chemical in the human body, it can constrict blood vessels and cause hypertension. Valsartan - in a class of drugs that include losartan (Cozaar) and irbesartan (Avapro) - blocks that chemical, thereby minimizing health risks that it could cause. It is used as a long-term maintenance drug and is taken daily. It was developed by Novartis, and was approved by the FDA in 1996.
If you would like more information about Valsartan Mass Tort please call our office at 601-296-1082 to discuss your case.